190 related articles for article (PubMed ID: 28341718)
1. Relationships among Cortical Glutathione Levels, Brain Amyloidosis, and Memory in Healthy Older Adults Investigated In Vivo with
Chiang GC; Mao X; Kang G; Chang E; Pandya S; Vallabhajosula S; Isaacson R; Ravdin LD; ; Shungu DC
AJNR Am J Neuroradiol; 2017 Jun; 38(6):1130-1137. PubMed ID: 28341718
[TBL] [Abstract][Full Text] [Related]
2. Association of Serum Docosahexaenoic Acid With Cerebral Amyloidosis.
Yassine HN; Feng Q; Azizkhanian I; Rawat V; Castor K; Fonteh AN; Harrington MG; Zheng L; Reed BR; DeCarli C; Jagust WJ; Chui HC
JAMA Neurol; 2016 Oct; 73(10):1208-1216. PubMed ID: 27532692
[TBL] [Abstract][Full Text] [Related]
3. Cognitive deficits in non-demented diabetic elderly appear independent of brain amyloidosis.
Chiang GC; Chang E; Pandya S; Kuceyeski A; Hu J; Isaacson R; Ganzer C; Schulman A; Sobel V; Vallabhajosula S; ; Ravdin L
J Neurol Sci; 2017 Jan; 372():85-91. PubMed ID: 28017255
[TBL] [Abstract][Full Text] [Related]
4. Association Between Amyloid and Tau Accumulation in Young Adults With Autosomal Dominant Alzheimer Disease.
Quiroz YT; Sperling RA; Norton DJ; Baena A; Arboleda-Velasquez JF; Cosio D; Schultz A; Lapoint M; Guzman-Velez E; Miller JB; Kim LA; Chen K; Tariot PN; Lopera F; Reiman EM; Johnson KA
JAMA Neurol; 2018 May; 75(5):548-556. PubMed ID: 29435558
[TBL] [Abstract][Full Text] [Related]
5. Dynamic relationships between age, amyloid-β deposition, and glucose metabolism link to the regional vulnerability to Alzheimer's disease.
Oh H; Madison C; Baker S; Rabinovici G; Jagust W
Brain; 2016 Aug; 139(Pt 8):2275-89. PubMed ID: 27190008
[TBL] [Abstract][Full Text] [Related]
6. Amyloid burden and metabolic function in early-onset Alzheimer's disease: parietal lobe involvement.
Ossenkoppele R; Zwan MD; Tolboom N; van Assema DM; Adriaanse SF; Kloet RW; Boellaard R; Windhorst AD; Barkhof F; Lammertsma AA; Scheltens P; van der Flier WM; van Berckel BN
Brain; 2012 Jul; 135(Pt 7):2115-25. PubMed ID: 22556189
[TBL] [Abstract][Full Text] [Related]
7. Associations of the Top 20 Alzheimer Disease Risk Variants With Brain Amyloidosis.
Apostolova LG; Risacher SL; Duran T; Stage EC; Goukasian N; West JD; Do TM; Grotts J; Wilhalme H; Nho K; Phillips M; Elashoff D; Saykin AJ;
JAMA Neurol; 2018 Mar; 75(3):328-341. PubMed ID: 29340569
[TBL] [Abstract][Full Text] [Related]
8. Region-Specific Association of Subjective Cognitive Decline With Tauopathy Independent of Global β-Amyloid Burden.
Buckley RF; Hanseeuw B; Schultz AP; Vannini P; Aghjayan SL; Properzi MJ; Jackson JD; Mormino EC; Rentz DM; Sperling RA; Johnson KA; Amariglio RE
JAMA Neurol; 2017 Dec; 74(12):1455-1463. PubMed ID: 28973551
[TBL] [Abstract][Full Text] [Related]
9. Assessment of beta-amyloid in a frontal cortical brain biopsy specimen and by positron emission tomography with carbon 11-labeled Pittsburgh Compound B.
Leinonen V; Alafuzoff I; Aalto S; Suotunen T; Savolainen S; Någren K; Tapiola T; Pirttilä T; Rinne J; Jääskeläinen JE; Soininen H; Rinne JO
Arch Neurol; 2008 Oct; 65(10):1304-9. PubMed ID: 18695050
[TBL] [Abstract][Full Text] [Related]
10. Regional dynamics of amyloid-β deposition in healthy elderly, mild cognitive impairment and Alzheimer's disease: a voxelwise PiB-PET longitudinal study.
Villain N; Chételat G; Grassiot B; Bourgeat P; Jones G; Ellis KA; Ames D; Martins RN; Eustache F; Salvado O; Masters CL; Rowe CC; Villemagne VL;
Brain; 2012 Jul; 135(Pt 7):2126-39. PubMed ID: 22628162
[TBL] [Abstract][Full Text] [Related]
11. Role of β-Amyloidosis and Neurodegeneration in Subsequent Imaging Changes in Mild Cognitive Impairment.
Knopman DS; Jack CR; Lundt ES; Wiste HJ; Weigand SD; Vemuri P; Lowe VJ; Kantarci K; Gunter JL; Senjem ML; Mielke MM; Machulda MM; Roberts RO; Boeve BF; Jones DT; Petersen RC
JAMA Neurol; 2015 Dec; 72(12):1475-83. PubMed ID: 26437123
[TBL] [Abstract][Full Text] [Related]
12. Different definitions of neurodegeneration produce similar amyloid/neurodegeneration biomarker group findings.
Jack CR; Wiste HJ; Weigand SD; Knopman DS; Mielke MM; Vemuri P; Lowe V; Senjem ML; Gunter JL; Reyes D; Machulda MM; Roberts R; Petersen RC
Brain; 2015 Dec; 138(Pt 12):3747-59. PubMed ID: 26428666
[TBL] [Abstract][Full Text] [Related]
13. Brain amyloidosis ascertainment from cognitive, imaging, and peripheral blood protein measures.
Apostolova LG; Hwang KS; Avila D; Elashoff D; Kohannim O; Teng E; Sokolow S; Jack CR; Jagust WJ; Shaw L; Trojanowski JQ; Weiner MW; Thompson PM;
Neurology; 2015 Feb; 84(7):729-37. PubMed ID: 25609767
[TBL] [Abstract][Full Text] [Related]
14. Pittsburgh B Compound Positron Emission Tomography in Patients With AL Cardiac Amyloidosis.
Lee SP; Suh HY; Park S; Oh S; Kwak SG; Kim HM; Koh Y; Park JB; Kim HK; Cho HJ; Kim YJ; Kim I; Yoon SS; Seo JW; Paeng JC; Sohn DW
J Am Coll Cardiol; 2020 Feb; 75(4):380-390. PubMed ID: 32000949
[TBL] [Abstract][Full Text] [Related]
15. Cognitive and neuroimaging features and brain β-amyloidosis in individuals at risk of Alzheimer's disease (INSIGHT-preAD): a longitudinal observational study.
Dubois B; Epelbaum S; Nyasse F; Bakardjian H; Gagliardi G; Uspenskaya O; Houot M; Lista S; Cacciamani F; Potier MC; Bertrand A; Lamari F; Benali H; Mangin JF; Colliot O; Genthon R; Habert MO; Hampel H;
Lancet Neurol; 2018 Apr; 17(4):335-346. PubMed ID: 29500152
[TBL] [Abstract][Full Text] [Related]
16. Sex differences in the association between amyloid and longitudinal brain volume change in cognitively normal older adults.
Armstrong NM; Huang CW; Williams OA; Bilgel M; An Y; Doshi J; Erus G; Davatzikos C; Wong DF; Ferrucci L; Resnick SM
Neuroimage Clin; 2019; 22():101769. PubMed ID: 30927602
[TBL] [Abstract][Full Text] [Related]
17. Association of anxiety with subcortical amyloidosis in cognitively normal older adults.
Hanseeuw BJ; Jonas V; Jackson J; Betensky RA; Rentz DM; Johnson KA; Sperling RA; Donovan NJ
Mol Psychiatry; 2020 Oct; 25(10):2599-2607. PubMed ID: 30116029
[TBL] [Abstract][Full Text] [Related]
18. Relationships between objectives sleep parameters and brain amyloid load in subjects at risk for Alzheimer's disease: the INSIGHT-preAD Study.
Ettore E; Bakardjian H; Solé M; Levy Nogueira M; Habert MO; Gabelle A; Dubois B; Robert P; David R
Sleep; 2019 Sep; 42(9):. PubMed ID: 31267124
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathologic and 11C-Pittsburgh compound B implications of Thal amyloid phase across the Alzheimer's disease spectrum.
Murray ME; Lowe VJ; Graff-Radford NR; Liesinger AM; Cannon A; Przybelski SA; Rawal B; Parisi JE; Petersen RC; Kantarci K; Ross OA; Duara R; Knopman DS; Jack CR; Dickson DW
Brain; 2015 May; 138(Pt 5):1370-81. PubMed ID: 25805643
[TBL] [Abstract][Full Text] [Related]
20. Independent contribution of temporal beta-amyloid deposition to memory decline in the pre-dementia phase of Alzheimer's disease.
Chételat G; Villemagne VL; Pike KE; Ellis KA; Bourgeat P; Jones G; O'Keefe GJ; Salvado O; Szoeke C; Martins RN; Ames D; Masters CL; Rowe CC;
Brain; 2011 Mar; 134(Pt 3):798-807. PubMed ID: 21310725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
